Teva Pharma (TEVA) Cut to Junk by S&P; to BB/Stable from BBB-/Watch
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $38.98 -0.54%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) Cut to Junk at S&P; to BB/Stable from BBB-/Watch
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva shares Phase 3 data on once-monthly schizophrenia injection
- Teva Pharma (TEVA) call put ratio 1.7 calls to 1 put as share price down 0.79%
- HF Foods ends $100M at-the-market stock offering program
Create E-mail Alert Related Categories
Corporate News, Credit RatingsRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
